SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 81 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $37,714,000 | -20.7% | 5,042,009 | +15.1% | 0.18% | -31.5% |
| Q4 2020 | $47,545,000 | +31.1% | 4,381,992 | +4.8% | 0.27% | -15.9% |
| Q3 2020 | $36,261,000 | -6.8% | 4,182,346 | -11.3% | 0.32% | -36.9% |
| Q2 2020 | $38,887,000 | -33.4% | 4,713,594 | -52.1% | 0.51% | -7.1% |
| Q1 2020 | $58,412,000 | +69.9% | 9,850,412 | +98.0% | 0.55% | +1.3% |
| Q4 2019 | $34,375,000 | -28.5% | 4,974,662 | +7.4% | 0.54% | -36.7% |
| Q3 2019 | $48,099,000 | +73.8% | 4,633,773 | +55.1% | 0.86% | +57.5% |
| Q2 2019 | $27,667,000 | +342.2% | 2,987,763 | +336.5% | 0.54% | +229.1% |
| Q1 2019 | $6,256,000 | +56772.7% | 684,475 | +33768.1% | 0.16% | – |
| Q4 2018 | $11,000 | -56.0% | 2,021 | -1.4% | 0.00% | -100.0% |
| Q3 2018 | $25,000 | – | 2,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |